JPH0565268A - Azetidinone derivative and production thereof - Google Patents

Azetidinone derivative and production thereof

Info

Publication number
JPH0565268A
JPH0565268A JP3109904A JP10990491A JPH0565268A JP H0565268 A JPH0565268 A JP H0565268A JP 3109904 A JP3109904 A JP 3109904A JP 10990491 A JP10990491 A JP 10990491A JP H0565268 A JPH0565268 A JP H0565268A
Authority
JP
Japan
Prior art keywords
formula
group
general formula
acid
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3109904A
Other languages
Japanese (ja)
Other versions
JP2669955B2 (en
Inventor
Osamu Sakanaka
治 阪中
Shohei Yasuda
昌平 安田
Shinjiro Washimi
信二郎 鷲見
Katsuharu Iinuma
勝春 飯沼
Takeshi Nishihata
健 西端
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP3109904A priority Critical patent/JP2669955B2/en
Priority to DE69223663T priority patent/DE69223663T2/en
Priority to EP92102776A priority patent/EP0500081B1/en
Priority to ES92102776T priority patent/ES2113382T3/en
Publication of JPH0565268A publication Critical patent/JPH0565268A/en
Priority to US08/076,195 priority patent/US5405955A/en
Priority to US08/282,005 priority patent/US5596096A/en
Application granted granted Critical
Publication of JP2669955B2 publication Critical patent/JP2669955B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Cephalosporin Compounds (AREA)

Abstract

PURPOSE:To provide new compounds useful as an intermediate for synthesis of cephalosporin-based antibiotics. CONSTITUTION:Compounds of formula I (R<1> is H or carboxylic acid-protecting group; Ar is aryl), e.g. p-methoxybenzyl-2-[3-amino-4-(p-toluene) sulfonylthio-2- azetidinon-1-yl]-3-chloromethyl-3-butenoate. The compound of formula I can be produced by reacting a chlorothiazolidineazetidinone derivatice of formula II (R<2> is aryl or aryloxy; R<3>CO is carboxylic acid residue) with an arylsulfinic acid of formula Ar-SO2H in the presence of an acid (e.g. hydrochloric acid) in a lower alcohol (e.g. methanol) at -20-50 deg.C for 30min-10hr. An economical penicillin can be used as the raw material for production.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は,一般式(1)で示され
る文献未載の新規なアゼチジノン誘導体およびその製造
法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel azetidinone derivative represented by the general formula (1), which has not been published in the literature, and a method for producing the same.

【0002】本発明で製造される一般式(1)で示され
るアゼチジノン誘導体はセファロスポリン系抗生物質の
重要な合成中間体であり,例えば本出願人の同日出願に
係る特願平3− 号明細書(発明の名称:7−アミ
ノ−3−クロロメチル−3−セフェム誘導体の製法)の
方法によれば次の反応式(A)に示す如く,セファロス
ポリン誘導体(4)に容易に変換が可能である。
The azetidinone derivative represented by the general formula (1) produced by the present invention is an important synthetic intermediate for cephalosporin antibiotics, and for example, Japanese Patent Application No. 3-53 filed on the same day by the present applicant. According to the method of the specification (title of the invention: a method for producing a 7-amino-3-chloromethyl-3-cephem derivative), the compound can be easily converted into a cephalosporin derivative (4) as shown in the following reaction formula (A). Is possible.

【化4】 上記化合物(4)は,例えば7位アミノ基をアシル化
し,3位クロロメチル基を芳香族ヘテロ環チオールで置
換し,さらにカルボン酸保護基を除去することによって
容易に種々のセファロスポリン系抗生物質へ変換可能な
重要な合成中間体として知られており,産業上の利用価
値は極めて高い。
[Chemical 4] The above compound (4) can be easily converted into various cephalosporin antibiotics by acylating the amino group at the 7-position, substituting the chloromethyl group at the 3-position with an aromatic heterocyclic thiol and further removing the carboxylic acid protecting group. It is known as an important synthetic intermediate that can be converted into a substance, and its industrial utility value is extremely high.

【0003】[0003]

【従来の技術】本発明による一般式(1)で表される誘
導体の既知類似化合物としては,鳥居滋ら(特開昭58
−85894,59−164771)の例があるが,そ
れらはいずれも例えば,次式(5)に示すが如くアミノ
2. Description of the Related Art Known analogues of the derivative represented by the general formula (1) according to the present invention include Shigeru Torii et al.
-85894, 59-164771), and all of them are, for example, amino groups as shown in the following formula (5).

【化5】 がアシル基で保護された型を取っている。従って,後の
工程でこのアシル基を切断する操作を改めて行なわねば
ならない。本発明に於ては,全くその必要がない。
[Chemical 5] Is in the form protected by an acyl group. Therefore, the operation of cleaving this acyl group must be performed again in a later step. In the present invention, this is not necessary at all.

【0004】[0004]

【発明が解決しようとする課題】簡便な方法を用いて,
一般式(2)で表されるチアゾリジンアゼチジノン誘導
体をセファロスポリン誘導体(4)を得るための合成前
駆体である一般式(1)で表されるアゼチジノン誘導体
へ高収率で変換することにある。
[Problems to be Solved by the Invention] Using a simple method,
To convert a thiazolidine azetidinone derivative represented by the general formula (2) into a azetidinone derivative represented by the general formula (1) which is a synthetic precursor for obtaining a cephalosporin derivative (4) in high yield. is there.

【0005】[0005]

【課題を解決するための手段】本発明に供する出発物質
(2)は下記反応式(C)に示す如く,ペニシリンスル
ホキシド(6)から容易に合成し得る化合物である。
The starting material (2) used in the present invention is a compound which can be easily synthesized from penicillin sulfoxide (6) as shown in the following reaction formula (C).

【化6】 化合物(6)から(7)への変換はR.D.G.Coo
perらによる方法(J.Am.Chem.Soc.,
92,2575(1970))によって,また,化合物
(7)から(8)を経て(9)への変換はS.J.Ea
gleらによる方法(Tetrahedron Let
t.,1978,4703)によって行うことが出来
る。また,化合物(9)から(2)へのクロル化反応は
本出願人の同日出願に係る特願平3− 号明細書
(発明の名称:チアゾリジンアゼチジノン誘導体及びそ
の製造法)の方法に従えば容易に行なうことが出来る。
チアゾリジンアゼチジノン誘導体(2)において,
,R及びRは特に限定されないが,通常のペニ
シリン−セファロスポリン変換で汎用される保護基が用
いられる。例えば,Rの具体例としては,ベンジル
基,パラニトベンジル基,パラメトキシベンジル基,ジ
フェニルメチル基等の置換もしくは置換基を有しないフ
ェニルメチル基,メチル基,エチル基,2,2,2−ト
リクロロエチル基等のハロゲンを含むことのある低級ア
ルキル基等が挙げられる。Rの具体例としては,フェ
ニル基,パラニトロフェニル基,パラクロロフェニル基
等の置換もしくは置換基を有しないアリール基,フェノ
キシ基,パラクロロフェノキシ基等の置換もしくは置換
基を有しないアリールオキシ基等を挙げることが出来
る。Rの具体例としては,水素原子,メチル基,エチ
ル基,n−ブチル基等のアルキル基,フェニル基,パラ
トルイル基,パラニトロフェニル基,パラクロロフェニ
ル基等の置換もしくは置換基を有しないアリール基等が
挙げられる。また,Arの具体例としては,フェニル
基,パラトルイル基,パラクロロフェニル基,パラニト
ロフェニル基,パラメトキシフェニル基,2,4−ジニ
トロフェニル基等の置換もしくは置換基を有しないアリ
ール基等が挙げられる。
[Chemical 6] Conversion of compound (6) to (7) is described in R.H. D. G. Coo
per et al. (J. Am. Chem. Soc.,
92 , 2575 (1970)) and the conversion of compound (7) to (9) via (8) by S. J. Ea
gle et al. (Tetrahedron Let
t. , 1978 , 4703). The chlorination reaction from compound (9) to (2) can be carried out according to the method of Japanese Patent Application No. 3- (Tiazolidine azetidinone derivative and its production method) filed on the same day by the applicant. It can be done easily.
In the thiazolidine azetidinone derivative (2),
R 1 , R 2 and R 3 are not particularly limited, but a protecting group generally used in ordinary penicillin-cephalosporin conversion is used. For example, specific examples of R 1 include a phenylmethyl group, a methyl group, an ethyl group, 2,2,2, such as a benzyl group, a paranitobenzyl group, a paramethoxybenzyl group, a diphenylmethyl group and the like, which may be substituted or unsubstituted. -A lower alkyl group which may contain halogen such as a trichloroethyl group. Specific examples of R 2 include a substituted or unsubstituted aryl group such as a phenyl group, a paranitrophenyl group and a parachlorophenyl group, and a substituted or unsubstituted aryloxy group such as a phenoxy group and a parachlorophenoxy group. Etc. can be mentioned. Specific examples of R 3 include a hydrogen atom, an alkyl group such as a methyl group, an ethyl group, and an n-butyl group, a phenyl group, a paratoluyl group, a paranitrophenyl group, a parachlorophenyl group, or a substituted or unsubstituted aryl group. Groups and the like. Specific examples of Ar include a phenyl group, a paratoluyl group, a parachlorophenyl group, a paranitrophenyl group, a paramethoxyphenyl group, an aryl group which does not have a substituent such as a 2,4-dinitrophenyl group, and the like. Be done.

【0006】本発明の方法は,チアゾリジンアゼチジノ
ン誘導体(2)をメタノール等の低級アルコールを含む
有機溶媒中に1モル/1〜0.01モル/1の濃度で溶
解し,これに塩酸等の酸とアリールスルフィン酸または
その金属塩とを加えて反応させる。反応温度および反応
時間は用いるチアゾリジンアゼチジノン誘導体(2)の
種類により一定しないが,反応温度は−20〜50℃が
好ましくは,更に好ましくは−5〜25℃であり,また
反応時間については,通常30分〜10時間で反応は完
結する。アリールスルフィン酸(3)はチアゾリジンア
ゼチジノン誘導体(2)に対し通常1.0〜5.0倍モ
ル,好ましくは1.05〜1.20倍モル用いられる。
添加される酸としては,例えば塩酸,硫酸,燐酸等の鉱
酸,トリフルオロ酢酸,パラトルエンスルホン酸等の有
機酸等が用いられるが,好ましくは1〜20%メタノー
ル−塩酸である。酸の添加量としては,通常チアゾリジ
ンアゼチジノン誘導体(2)に対して0.1〜20倍モ
ル,好ましくは5〜10倍モルである。
In the method of the present invention, the thiazolidine azetidinone derivative (2) is dissolved in an organic solvent containing a lower alcohol such as methanol at a concentration of 1 mol / 1 to 0.01 mol / 1, and then dissolved in hydrochloric acid or the like. The acid and arylsulfinic acid or its metal salt are added and reacted. The reaction temperature and reaction time are not constant depending on the type of thiazolidine azetidinone derivative (2) used, but the reaction temperature is preferably -20 to 50 ° C, more preferably -5 to 25 ° C, and the reaction time is The reaction is usually completed in 30 minutes to 10 hours. The arylsulfinic acid (3) is generally used in an amount of 1.0 to 5.0 times, preferably 1.05 to 1.20 times the mol of the thiazolidine azetidinone derivative (2).
As the acid to be added, for example, mineral acids such as hydrochloric acid, sulfuric acid and phosphoric acid, organic acids such as trifluoroacetic acid and paratoluenesulfonic acid, and the like are used, and preferably 1 to 20% methanol-hydrochloric acid. The amount of the acid added is usually 0.1 to 20 times mol, preferably 5 to 10 times mol, of the thiazolidine azetidinone derivative (2).

【0007】有機溶媒としては低級アルコール単独ある
いは低級アルコールを少なくとも一種以上含む混合溶媒
が用いられる。低級アルコールの具体例としては,メタ
ノール,エタノール,n−ブタノール等であり,低級ア
ルコールと混合して用いられる有機溶媒としてはアセト
ン,メチルエチルケトン等のケトン類,アセトニトリ
ル,ブチロニトリル等のニトリル類,ジエチルエーテ
ル,ジイソプロピルエーテル,テトラヒドロフラン,
1,4−ジオキサン等のエーテル類,ニトロメタン,ジ
クロロメタン,クロロホルム,1,2−ジクロロエタ
ン,四塩化炭素等のハロゲン化炭化水素系溶媒,ベンゼ
ン,トルエン,クロロベンゼン等の芳香族系溶媒,酢酸
エチル,蟻酸メチル等のエステル類,ジメチルホルムア
ミド,ジメチルアセトアミド等のアミド類等が挙げられ
る。
As the organic solvent, a lower alcohol alone or a mixed solvent containing at least one lower alcohol is used. Specific examples of the lower alcohol include methanol, ethanol, n-butanol and the like. Organic solvents used by mixing with the lower alcohol include acetone, ketones such as methyl ethyl ketone, acetonitrile, nitriles such as butyronitrile, diethyl ether, Diisopropyl ether, tetrahydrofuran,
Ethers such as 1,4-dioxane, nitromethane, dichloromethane, chloroform, 1,2-dichloroethane, halogenated hydrocarbon solvents such as carbon tetrachloride, aromatic solvents such as benzene, toluene and chlorobenzene, ethyl acetate, formic acid Examples thereof include esters such as methyl and amides such as dimethylformamide and dimethylacetamide.

【0008】このようにして製造される本発明の化合物
は通常の分離手段により容易に単離精製される。
The compound of the present invention thus produced is easily isolated and purified by a conventional separation means.

【0009】[0009]

【実施例】【Example】

実施例1 p−メトキシベンジル 2−(3−アミノ−4−(p−
トルエン)スルホニルチオ−2−アゼチジノン−1−イ
ル)−3−クロロメチル−3−ブテノエート(1a)
(R=p−メトキシベンジル,Ar=p−トルイル)
化合物(2a)(R=p−メトキシベンジル,R
フェニル,R=水素)500mgを塩化メチレン1.
5mlとメタノール10mlとの混液に溶解し,氷冷下
6N−塩酸1ml及びパラトルエンスルフィン酸166
mgを加えて,室温で4時間反応した。反応液を塩化メ
チレン50mlと水50mlとの混液に注ぎ,分液後水
層をさらに塩化メチレン10mlで抽出し,合併した有
機層を無水硫酸ナトリウムで乾燥後,減圧濃縮乾固し
た。残渣を逆相C18(ナカライテスク コスモシール
75C18OPN,50g)を用いたカラムクロマトグ
ラフィー(アセトニトリル−水 3:2)にて精製し,
化合物(la)428mg(84%)を淡黄色シロップ
として得た。 H−NMR(CDCl) δ 1.78(bs,2H,NH),2.44
(s,3H,SOCH),3.80(s,
3H,CHOCH),4.07(s,2
H,CHOCH),4.63(d,1H,
J=4.5Hz,β−ラクタム),4.93,5.0
7,5.37(各s,各1H,C(COOCH
OCH)C(CHCl)=C ),5.10
(d,1H,J=10.8Hz,CHCl),5.I
7(d,1H,J=10.8Hz,CHCl),5.
53(d,1H,J=4.5Hz,β−ラクタム),
6,89(d,2H,J=9.0Hz,CH
OCH),7.28(d,2H,J=9.0Hz,C
OCH),7.33(d,2H,J=
8.4Hz,SOCH),7.77(d,
2H,J=8.4Hz,SOCH IR 3400,3340,1775,
1740,1335,1145cm−1
 Example 1 p-methoxybenzyl 2- (3-amino-4- (p-
Toluene) sulfonylthio-2-azetidinone-1-i
) -3-Chloromethyl-3-butenoate (1a)
(R1= P-methoxybenzyl, Ar = p-toluyl)
Compound (2a) (R1= P-methoxybenzyl, RTwo=
Phenyl, RThree= Hydrogen) 500 mg of methylene chloride 1.
Dissolve in a mixture of 5 ml and 10 ml of methanol, and under ice cooling
6N-hydrochloric acid 1 ml and paratoluenesulfinic acid 166
mg was added and reacted at room temperature for 4 hours. The reaction solution is
Pour into a mixture of 50 ml of ethylene and 50 ml of water, and after separating,
The layers were further extracted with 10 ml of methylene chloride and merged.
The organic layer was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to dryness.
It was The residue is reverse phase C18(Nacalai Tesque Cosmo Seal
75C18Column chromatography using OPN, 50g)
Purify with Raffy (acetonitrile-water 3: 2),
Compound (la) 428 mg (84%) as a pale yellow syrup
Got as.1 H-NMR (CDClThree) Δ 1.78 (bs, 2H, NHTwo), 2.44
(S, 3H, SOTwoC6HFourCHThree), 3.80 (s,
3H, CHTwoC6HFourOCHThree), 4.07 (s, 2
H, CHTwoC6HFourOCHThree), 4.63 (d, 1H,
J = 4.5 Hz, β-lactam), 4.93, 5.0
7, 5.37 (each s, each 1H, CH(COOCHTwoC6
HFourOCHThree) C (CHTwoCl) = CH 2 ), 5.10
(D, 1H, J = 10.8Hz, CHTwoCl), 5. I
7 (d, 1H, J = 10.8Hz, CHTwoCl), 5.
53 (d, 1H, J = 4.5 Hz, β-lactam),
6,89 (d, 2H, J = 9.0Hz, CHTwoC6HFour
OCHThree), 7.28 (d, 2H, J = 9.0 Hz, C
HTwoC6HFourOCHThree), 7.33 (d, 2H, J =
8.4Hz, SOTwoC6HFourCHThree), 7.77 (d,
2H, J = 8.4Hz, SOTwoC6HFourCHThree  IR 3400, 3340, 1775,
1740, 1335, 1145 cm-1

【0010】実施例2 p−メトキシベンジル 2−(3−アミノ−4−ベンゼ
ンスルホニルチオ−2−アゼチジノン−1−イル)−3
−クロロメチル−3−ブテノエート(1b)(R=パ
ラメトキシベンジル,Ar=フェニル)
Example 2 p-Methoxybenzyl 2- (3-amino-4-benzenesulfonylthio-2-azetidinone-1-yl) -3
-Chloromethyl-3-butenoate (1b) (R 1 = paramethoxybenzyl, Ar = phenyl)

【0011】化合物(2b)(R=p−メトキシベン
ジル,R=フェニル,R=水素)500mgを塩化
メチレン1.5mlとメタノール4mlとの混液に溶解
し,氷冷下1N−塩化水素/メタノール6mlとベンゼ
ンスルフィン酸ナトリウム2水和物213mgを加え
て,室温で3時間反応した。実施例1と同様の操作を行
ない,化合物(1b)443mg(87%)を淡黄色シ
ロップとして得た。 H−NMR(CDCl) δ 1.80(bs,2H,NH),3.80
(s,3H,CHOCH),4.05
(s,2H,CHOCH),4.63
(d,1H,J=4.5Hz,β−ラクタム),4.9
2,5.01,5.33(各s,各1H,C(COO
CHOCH)C(CHCl)=C
),5.09(d,1H,J=10.8Hz,CH
Cl),5.I6(d,1H,J=10.8Hz,C
Cl),5.55(d,1H,J=4.5Hz,β
−ラクタム),6,89(d,2H,J=9.0Hz,
CHOCH),7.28(d,2H,J=
9.0Hz,CHOCH),7.51−
7.89(5H,m,SO IR 3400,3340,1775,
1740,1335,1145cm−1
Compound (2b) (R1= P-methoxyben
Jill, RTwo= Phenyl, RThree= Hydrogen) Chloride 500 mg
Dissolved in a mixture of 1.5 ml of methylene and 4 ml of methanol
Then, under ice cooling, 1N-hydrogen chloride / methanol 6 ml and benz
213mg sodium sodium sulfinate dihydrate
And reacted at room temperature for 3 hours. Perform the same operation as in Example 1.
No, compound (1b) 443 mg (87%)
Got it as a lop.1 H-NMR (CDClThree) Δ 1.80 (bs, 2H, NHTwo), 3.80
(S, 3H, CHTwoC6HFourOCHThree), 4.05
(S, 2H, CHTwoC6HFourOCHThree), 4.63
(D, 1H, J = 4.5 Hz, β-lactam), 4.9
2, 5.01, 5.33 (each s, each 1H, CH(COO
CHTwoC6HFourOCHThree) C (CHTwoCl) = C
H 2 ), 5.09 (d, 1H, J = 10.8Hz, CH
TwoCl), 5. I6 (d, 1H, J = 10.8Hz, C
HTwoCl), 5.55 (d, 1H, J = 4.5Hz, β
-Lactam), 6,89 (d, 2H, J = 9.0Hz,
CHTwoC6HFourOCHThree), 7.28 (d, 2H, J =
9.0Hz, CHTwoC6HFourOCHThree), 7.51-
7.89 (5H, m, SOTwoC6H5  IR 3400, 3340, 1775,
1740, 1335, 1145 cm-1

【0012】実施例3 p−メトキシベンジル 2−(3−アミノ−4−ベンゼ
ンスルホニルチオ−2−アゼチジノン−1−イル)−3
−クロロメチル−3−ブテノエート(1b)(R=p
−メトキシベンジル,Ar=フェニル) 化合物(2c)(R=p−メトキシベンジル,R
フェニル,R=メチル)1.0gを塩化メチレン3m
lとメタノール8mlとの混液に溶解し,氷冷下1N−
塩化水素/メタノール12mlとベンゼンスルフィン酸
ナトリウム2水和物450mgを加えて,室温で12時
間反応した。実施例1と同様の操作を行ない,化合物
(1b)797mg(82%)を得た。
Example 3 p-Methoxybenzyl 2- (3-amino-4-benzenesulfonylthio-2-azetidinone-1-yl) -3
-Chloromethyl-3-butenoate (1b) (R 1 = p
- methoxybenzyl, Ar = phenyl) Compound (2c) (R 1 = p- methoxybenzyl, R 2 =
Phenyl, R 3 = methyl) 1.0 g methylene chloride 3 m
Dissolve in a mixed solution of 1 and 8 ml of methanol and 1N- under ice cooling.
Hydrogen chloride / methanol (12 ml) and sodium benzenesulfinate dihydrate (450 mg) were added, and the mixture was reacted at room temperature for 12 hours. The same operation as in Example 1 was performed to obtain 797 mg (82%) of the compound (1b).

【0013】[0013]

【発明の効果】本発明による一般式(1)で表されるア
ゼチジノン誘導体は,本発明者らの方法である上記反応
式(A)を経て,種々のセファロスポリン系抗生物質の
重要合成中間体(4)へ容易に変換し得る。この点にお
いて本発明は医薬製造産業上,極めて利用価値が大き
く,また安価なペニシリンを原料として利用できること
から各種セファロスポリン系抗生物質の製造原価低減化
に大きく寄与し得るものと考えられる。
Industrial Applicability The azetidinone derivative represented by the general formula (1) according to the present invention undergoes an important synthetic intermediate of various cephalosporin antibiotics through the above reaction formula (A) which is the method of the present inventors. It can be easily converted to the body (4). In this respect, the present invention has a great utility value in the pharmaceutical manufacturing industry, and since inexpensive penicillin can be used as a raw material, it is considered that the present invention can greatly contribute to the reduction of the manufacturing cost of various cephalosporin antibiotics.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 飯沼 勝春 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 (72)発明者 西端 健 神奈川県横浜市港北区師岡町760番地 明 治製菓株式会社薬品総合研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Katsuharu Iinuma 760, Shimooka-cho, Kohoku-ku, Yokohama-shi, Kanagawa Meiji Confectionery Co., Ltd., Pharmaceutical Research Laboratory (72) Inventor Ken Nishibata 760, Shimooka-cho, Kohoku-ku, Yokohama-shi, Kanagawa Meiji Seika Co., Ltd. Pharmaceutical Research Institute

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 一般式(1) 【化1】 (式中,Rは水素原子またはカルボン酸保護基を示
し,Arは置換もしくは置換基を有しないアリール基を
示す。)で表されるアゼチジノン誘導体。
1. A compound represented by the general formula (1): (In the formula, R 1 represents a hydrogen atom or a carboxylic acid protecting group, and Ar represents a substituted or unsubstituted aryl group.) An azetidinone derivative represented by the following formula.
【請求項2】 請求項1の一般式(1)においてR
パラメトキシベンジル,Arがパラトルイル又はフェニ
ルであるアゼチジノン誘導体。
2. An azetidinone derivative in which R 1 is paramethoxybenzyl and Ar is paratoluyl or phenyl in the general formula (1) of claim 1.
【請求項3】 酸の存在下,低級アルコールを含む有機
溶媒中にて,一般式(2) 【化2】 (式中,Rは置換もしくは置換基を有しないアリール
基,又は置換もしくは置換基を有しないアリールオキシ
基を示し,RCOはカルボン酸残基を示し,Rは前
記に同じ。)で表されるチアゾリジンアゼチジノン誘導
体と一般式(3) 【化3】 (式中,Arは前記に同じ。)で表されるアリールスル
フィン酸とを反応させて得られる請求項1の一般式
(1)で表されるアゼチジノン誘導体の製造法。
3. A compound represented by the general formula (2): embedded image in an organic solvent containing a lower alcohol in the presence of an acid. (In the formula, R 2 represents a substituted or non-substituted aryl group or a substituted or non-substituted aryloxy group, R 3 CO represents a carboxylic acid residue, and R 1 is the same as above.) A thiazolidineazetidinone derivative represented by the general formula (3) (In the formula, Ar is the same as the above.) The manufacturing method of the azetidinone derivative represented by General formula (1) of Claim 1 obtained by making it react with arylsulfinic acid.
【請求項4】 メタノール−塩酸を含む有機溶媒中に
て,請求項3の一般式(2)においてRがパラメトキ
シベンジル,Rがフェニル,Rが水素原子またはメ
チルであるチアゾリジンアゼチジノン誘導体と請求項3
の一般式(3)においてArがパラトルイルまたはフェ
ニルであるスルフィン酸とを反応させて得られる請求項
1の一般式(1)で表されるアゼチジノン誘導体の製造
法。
4. A thiazolidine azetidinone in which R 1 is paramethoxybenzyl, R 2 is phenyl and R 3 is a hydrogen atom or methyl in an organic solvent containing methanol-hydrochloric acid. Derivatives and claim 3
The method for producing an azetidinone derivative represented by the general formula (1) according to claim 1, which is obtained by reacting with sulfinic acid in which Ar is paratoluyl or phenyl in the general formula (3).
JP3109904A 1991-02-20 1991-02-20 Azetidinone derivative and method for producing the same Expired - Lifetime JP2669955B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP3109904A JP2669955B2 (en) 1991-02-20 1991-02-20 Azetidinone derivative and method for producing the same
DE69223663T DE69223663T2 (en) 1991-02-20 1992-02-19 Azetidinone derivatives and process for the preparation of azetidinone and cefalosporin derivatives
EP92102776A EP0500081B1 (en) 1991-02-20 1992-02-19 Azetidinone derivatives and method for producing azetidinone and cephalosporin derivatives
ES92102776T ES2113382T3 (en) 1991-02-20 1992-02-19 AZETIDINONE DERIVATIVES AND PROCEDURE FOR PRODUCING AZETIDINONE AND CEPHALOSPORIN DERIVATIVES.
US08/076,195 US5405955A (en) 1991-02-20 1993-06-14 Method for producing azetidinone and cephalosporin derivatives
US08/282,005 US5596096A (en) 1991-02-20 1994-07-29 Azetidinone derivatives and method for producing azetidinone and cephalosoporin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3109904A JP2669955B2 (en) 1991-02-20 1991-02-20 Azetidinone derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0565268A true JPH0565268A (en) 1993-03-19
JP2669955B2 JP2669955B2 (en) 1997-10-29

Family

ID=14522107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3109904A Expired - Lifetime JP2669955B2 (en) 1991-02-20 1991-02-20 Azetidinone derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JP2669955B2 (en)

Also Published As

Publication number Publication date
JP2669955B2 (en) 1997-10-29

Similar Documents

Publication Publication Date Title
EP0023097B1 (en) De-arylmethylation of n-mono- or n-diarylmethyl-beta-lactams; novel azetizinones having anti-bacterial activity
US4060688A (en) Cephalosporin intermediates
US4071529A (en) Derivatives of 6-aminopenicillanic acid
US4122086A (en) Isopenicillins
EP0018546B1 (en) Process for the production of phenylglycyl chloride hydrochlorides
US4057540A (en) 4-Chloroazetidinone-1-(2&#39;,3&#39;-dichloroisopropyl) acetates and process for preparing same
JP2669955B2 (en) Azetidinone derivative and method for producing the same
JPH0141152B2 (en)
US4566996A (en) Process for preparing azetidinone derivatives
JP2595605B2 (en) Method for producing 2-substituted oxyimino-3-oxobutyric acid
US4103086A (en) 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
EP0117872B1 (en) Process for preparing cephalosporin compounds
JP2669961B2 (en) Azetidinone derivatives and their production
KR910005230B1 (en) Process for producing azetidinones
EP0122002B1 (en) Process for preparing azetidinone derivatives
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
US4798890A (en) Process for preparation of azetidinone derivatives
US4560750A (en) Cephem compounds and process for preparing the same
US4556513A (en) Process for the production of antibiotic 1-oxadethiacephalosporins, and intermediate
EP0081824B1 (en) Processes for the production of antibiotic 1-oxadethiacephalosporins
US4183850A (en) Process for preparing 2-acyloxymethylpenams and 3-acyloxycephams
JP2661810B2 (en) Method for producing 7-amino-3-chloromethyl-3-cephem derivative
JPH069646A (en) Preparation of exomethylenecephams
US4740596A (en) Process for preparation of 4-sulfonylthio azetidinone derivatives
US4472576A (en) Processes for the production of antibiotic 1-oxadethiacephalosporins